Benzamide,3,5-dibromo-N-(4-bromophenyl)-2-hydroxy- structure
|
Common Name | Benzamide,3,5-dibromo-N-(4-bromophenyl)-2-hydroxy- | ||
|---|---|---|---|---|
| CAS Number | 87-10-5 | Molecular Weight | 449.92000 | |
| Density | 1.135g/cm3 | Boiling Point | 367.7ºC at 760 mmHg | |
| Molecular Formula | C13H8Br3NO2 | Melting Point | 223-224°C | |
| MSDS | N/A | Flash Point | 146.3ºC | |
| Name | tribromosalicylanilide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.135g/cm3 |
|---|---|
| Boiling Point | 367.7ºC at 760 mmHg |
| Melting Point | 223-224°C |
| Molecular Formula | C13H8Br3NO2 |
| Molecular Weight | 449.92000 |
| Flash Point | 146.3ºC |
| Exact Mass | 446.81100 |
| PSA | 49.33000 |
| LogP | 5.00500 |
| Index of Refraction | 1.57 |
| InChIKey | KVSKGMLNBAPGKH-UHFFFAOYSA-N |
| SMILES | O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Risk Phrases | R22:Harmful if swallowed. |
|---|---|
| Safety Phrases | S20/21 |
| RTECS | VN8925000 |
| HS Code | 2924299090 |
|
~94%
Benzamide,3,5-d... CAS#:87-10-5 |
| Literature: Waisser, Karel; Hladuvkova, Jana; Gregor, Jiri; Rada, Tomas; Kubicova, Lenka; Klimesova, Vera; Kaustova, Jarmila Archiv der Pharmazie, 1998 , vol. 331, # 1 p. 3 - 6 |
|
~%
Benzamide,3,5-d... CAS#:87-10-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 24, # 10 p. 1245 - 1249 |
|
~%
Benzamide,3,5-d... CAS#:87-10-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 24, # 10 p. 1245 - 1249 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Trisanil |
| MFCD00045740 |
| Tribromosalan |
| Temasept IV |
| Tempasept II |
| 3,5-dibromo-N-(4-bromo-phenyl)-2-hydroxy-benzamide |
| Trisanyl |
| Tribromsalanum |
| Temasept II |
| EINECS 201-723-6 |
| Agramed |
| Tribromsalan |
| 3,5-dibromo-N-(4-bromophenyl)-2-hydroxybenzamide |